Nguyen Duc at press conference in Tokyo

Nguyen Duc at press conference in Tokyo

TOKYO, Japan - Nguyen Duc, who was born as a conjoined twin, apparently due to the effects of Agent Orange used by the U.S. military during the Vietnam War, gives a press conference in Tokyo, on Aug. 4, 2014, calling for ongoing support for people affected by the toxic defoliant.

  • Product Code
  • ILEA001204778
  • Registered date
  • 2014/8/04 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2014 Kyodo News
  • Media size
  • 1068 × 894 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 158.27(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan finance minister Suzuki on currency market

    Japan finance minister Suzuki on currency market

    Japanese Finance Minister Shunichi Suzuki holds a press conference at the ministry in Tokyo on July 12, 2024. He declined to comment on whether Japan had intervened in the currency market overnight to shore up the yen against the U.S. dollar.
      KDDI to deploy drones to aid disaster relief

      KDDI to deploy drones to aid disaster relief

      A drone flies in the dark during a demonstration at a KDDI Corp. press conference in Tokyo on May 13, 2024. In partnership with U.S. drone company Skydio Inc., the Japanese telecom company plans to deploy such drones, equipped with cameras and sensors, at 1,000 locations across Japan in order to respond quickly to earthquakes and other natural disasters.
        KDDI to deploy drones to aid disaster relief

        KDDI to deploy drones to aid disaster relief

        A drone flies in the dark during a demonstration at a KDDI Corp. press conference in Tokyo on May 13, 2024. In partnership with U.S. drone company Skydio Inc., the Japanese telecom company plans to deploy such drones, equipped with cameras and sensors, at 1,000 locations across Japan in order to respond quickly to earthquakes and other natural disasters.
          Oracle to invest $8 bil. in Japan

          Oracle to invest $8 bil. in Japan

          U.S. IT firm Oracle Corp. CEO Safra Catz holds a press conference in Tokyo on April 18, 2024. She said the Japanese unit of Oracle Corp. will invest $8 billion in Japan over the next 10 years to respond to the country's growing demand for cloud computing and artificial intelligence.
            Oracle to invest $8 bil. in Japan

            Oracle to invest $8 bil. in Japan

            U.S. IT firm Oracle Corp. CEO Safra Catz holds a press conference in Tokyo on April 18, 2024. She said the Japanese unit of Oracle Corp. will invest $8 billion in Japan over the next 10 years to respond to the country's growing demand for cloud computing and artificial intelligence.

              Lviv mayor, Japanese architect call for support for building hospital

              Lviv Mayor Andriy Sadovyi and Japanese architect Shigeru Ban hold a press conference at the Foreign Correspondents' Club of Japan in Tokyo on Sept. 5, 2023. They called for Japan's support in building a new surgical ward designed by the architect at a hospital in Ukraine's western city of Lviv, which harbors many fleeing and injured civilians from the war-torn areas within the country.
                Keidanren head

                Keidanren head

                Masakazu Tokura, chairman of the Japan Business Federation, known as Keidanren, speaks at a press conference in Tokyo on Sept. 4, 2023.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.